VR
Veerappan Rajendran
About Veerappan Rajendran
Data last updated:
Veerappan Rajendran has 17 years in corporate governance. Holds Managing Director and Director roles. Currently with 2 companies, including Kovai Heart Foundation Private Limited and K K Medipharma Private Limited. Formerly with 1 company, such as Doctors' Hospital And Medical Center Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
 Kovai Heart Foundation Private Limited U85110TZ2009PTC015457 | Managing Director | 01 Sep 2009 | 2009 | Active |
 K K Medipharma Private Limited U24290TZ2023PTC040767 | Director | 09 Jan 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
| Doctors' Hospital And Medical Center Private Limited U85110TZ2015PTC021289 | Managing Director | 10 Apr 2015 | 2015 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Veerappan Rajendran
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Veerappan Rajendran
Veerappan Rajendran has 17 years in corporate governance. Holds Managing Director and Director roles. Currently with 2 companies, including Kovai Heart Foundation Private Limited and K K Medipharma Private Limited. Formerly with 1 company, such as Doctors' Hospital And Medical Center Private Limited. Engaged in General Business. Contributes to corporate operations.
Veerappan Rajendran is associated with 2 companies as Managing Director and Director.
Veerappan Rajendran has expertise in General Business.
Veerappan Rajendran has 17 years in corporate governance.